Estudio epidemiológico de la evolución clínica y microbiológica en Pacientes Tratadas Por un Episodio Agudo de Candidiasis Vulvovaginal

Dr. Santiago Palacios1 site in 1 country43 target enrollmentDecember 29, 2016

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Vulvovaginal Candidiases
Sponsor: Dr. Santiago Palacios
Enrollment: 43
Locations: 1
Primary Endpoint: Estimate cure rate in women with severe vuvovaginal candidiases infection
Status: Completed
Last Updated: 5 years ago

Epidemiological study about the clinical and microbiological progress in subjects under treatment for a severe vulvovaginal candidiases episody

Registry

clinicaltrials.gov

Start Date

December 29, 2016

End Date

June 30, 2019

Last Updated

5 years ago

Study Type

Observational

Sex

Female

Sponsor

Dr. Santiago Palacios

Responsible Party

Sponsor Investigator

Principal Investigator

Dr. Santiago Palacios

MD - Gynecologyst

Instituto Palacios

•Pregnant women
•Diabetes Mellitus
•Women witihin three months after a delivery or misbirth
•Women with vaginal or genital infection symptomatology other than candidiases that needs antibiotic treatment
•Vaginal probiotics use within last three months
•Undiagnosed abnormal genital hemorrhage

Estimate cure rate in women with severe vuvovaginal candidiases infection

Time Frame: At 3 months

Women must require antimicotic treatment plus vaginal probiotic following the habitual therapeutic standards

Evaluate the effectiveness of probiotic treatment by patient. A satisfaction questionnaire will be performed(At 3 months)
Estimate recurrences(At 12 months)
Evaluate the link between symptomatology and negative culture(At 3 months)
Evaluate the effectiveness of probiotic treatment by physician(At 3 months)